Literature DB >> 11936852

Variations in biochemical and pharmacological properties of Indian cobra (Naja naja naja) venom due to geographical distribution.

R Shashidharamurthy1, D K Jagadeesha, K S Girish, K Kemparaju.   

Abstract

Indian cobra (Naja naja naja) venom obtained from three different geographical regions was studied in terms of electrophoretic pattern, biochemical and pharmacological activities. SDS-PAGE banding pattern revealed significant variation in the protein constituents of the three regional venoms. The eastern venom showed highest indirect hemolysis and hyaluronidase activity. In contrast, western and southern venoms were rich in proteolytic activity. All the three regional venoms were devoid of p-tosyl-L-arginine methyl ester hydrolysing activity. The eastern venom was found to be most lethal among the three regional venoms. The lethal potency varied as eastern > western > southern regional venoms. In addition, all the three regional venoms showed marked variations in their ability to induce symptoms/signs of neurotoxicity, myotoxicity, edema and effect on plasma coagulation process. Polyclonal antiserum prepared against the venom of eastern region cross-reacted with both southern and western regional venoms, but varied in the extent of cross-reactivity by ouchterlony immunodiffusion and ELISA.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11936852     DOI: 10.1023/a:1017972511272

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  45 in total

1.  A method for the estimation of serum creatine kinase and its use in comparing creatine kinase and aldolase activity in normal and pathological sera.

Authors:  B P HUGHES
Journal:  Clin Chim Acta       Date:  1962-09       Impact factor: 3.786

2.  Studies on the quantitative method for determination of hemorrhagic activity of Habu snake venom.

Authors:  H KONDO; S KONDO; H IKEZAWA; R MURATA
Journal:  Jpn J Med Sci Biol       Date:  1960

3.  Chromatography of rattlesnake venom; a separation of three phosphodiesterases.

Authors:  H G BOMAN; U KALETTA
Journal:  Biochim Biophys Acta       Date:  1957-06

Review 4.  Snake venom variability: methods of study, results and interpretation.

Authors:  J P Chippaux; V Williams; J White
Journal:  Toxicon       Date:  1991       Impact factor: 3.033

5.  Kinetics of erythrocyte lysis by snake venom cardiotoxins.

Authors:  A I Louw; L Visser
Journal:  Biochim Biophys Acta       Date:  1977-06-23

6.  Snake bite in India and its management.

Authors:  S Mitra
Journal:  J Indian Med Assoc       Date:  1987-05

7.  Approximate LD50 determinations of snake venoms using eight to ten experimental animals.

Authors:  J Meier; R D Theakston
Journal:  Toxicon       Date:  1986       Impact factor: 3.033

8.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

9.  Characterization of three edema-inducing phospholipase A2 enzymes from habu (Trimeresurus flavoviridis) venom and their interaction with the alkaloid aristolochic acid.

Authors:  B S Vishwanath; R M Kini; T V Gowda
Journal:  Toxicon       Date:  1987       Impact factor: 3.033

10.  Intergradation of two different venom populations of the Mojave rattlesnake (Crotalus scutulatus scutulatus) in Arizona.

Authors:  J L Glenn; R C Straight
Journal:  Toxicon       Date:  1989       Impact factor: 3.033

View more
  22 in total

1.  Snake venom hyaluronidase: an evidence for isoforms and extracellular matrix degradation.

Authors:  K S Girish; D K Jagadeesha; K B Rajeev; K Kemparaju
Journal:  Mol Cell Biochem       Date:  2002-11       Impact factor: 3.396

2.  Strong myotoxic activity of Trimeresurus malabaricus venom: role of metalloproteases.

Authors:  C D Raghavendra Gowda; R Rajesh; A Nataraju; B L Dhananjaya; A R Raghupathi; T V Gowda; B K Sharath; B S Vishwanath
Journal:  Mol Cell Biochem       Date:  2006-01       Impact factor: 3.396

Review 3.  Therapeutic potential of snake venom in cancer therapy: current perspectives.

Authors:  Vivek Kumar Vyas; Keyur Brahmbhatt; Hardik Bhatt; Utsav Parmar
Journal:  Asian Pac J Trop Biomed       Date:  2013-02

Review 4.  Evolution Bites - Timeworn Inefficacious Snakebite Therapy in the Era of Recombinant Vaccines.

Authors:  Navneet Kaur; Ashwin Iyer; Kartik Sunagar
Journal:  Indian Pediatr       Date:  2021-03-15       Impact factor: 1.411

Review 5.  New approaches & technologies of venomics to meet the challenge of human envenoming by snakebites in India.

Authors:  David A Warrell; José Maria Gutiérrez; Juan J Calvete; David Williams
Journal:  Indian J Med Res       Date:  2013       Impact factor: 2.375

6.  Histological, molecular and biochemical detection of renal injury after Echis pyramidum snake envenomation in rats.

Authors:  Awadh M Al-Johany; Mohamed K Al-Sadoon; Ahmed E Abdel Moneim; Amira A Bauomy; Marwa S M Diab
Journal:  Saudi J Biol Sci       Date:  2014-10-23       Impact factor: 4.219

7.  Cross-Reactivity against Naja sumatrana (Black Spitting Cobra) Envenoming from the Haffkine Antivenom in a Mouse Model.

Authors:  Gregory Cham; Francis Lim; Arul Earnest; Ponnampalam Gopalakrishnakone
Journal:  ISRN Toxicol       Date:  2013-08-12

8.  Comparative venom gland transcriptome surveys of the saw-scaled vipers (Viperidae: Echis) reveal substantial intra-family gene diversity and novel venom transcripts.

Authors:  Nicholas R Casewell; Robert A Harrison; Wolfgang Wüster; Simon C Wagstaff
Journal:  BMC Genomics       Date:  2009-11-30       Impact factor: 3.969

9.  Estimating epidemiological and economic burden and community derived disability weights for snake bite in Kerala: a study protocol.

Authors:  Jaideep C Menon; Denny John; Geeta R Menon; Joseph K Joseph; P Rakesh Suseela; V V Pillay; Amitava Banerjee
Journal:  F1000Res       Date:  2021-03-01

10.  Reappraisal of Vipera aspis venom neurotoxicity.

Authors:  Elisabeth Ferquel; Luc de Haro; Virginie Jan; Isabelle Guillemin; Sabine Jourdain; Alexandre Teynié; Jacques d'Alayer; Valérie Choumet
Journal:  PLoS One       Date:  2007-11-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.